세계의 이미징 CRO 시장 : 서비스 유형별, 이미징 모달리티별, 치료 영역별, 임상시험 단계별, 최종사용자별, 지역별
Imaging CRO Market, By Service Type, By Imaging Modality, By Therapeutic Area, By Clinical Trial Phase, By End User, By Geography
상품코드
:
1747272
리서치사
:
Coherent Market Insights
발행일
:
2025년 05월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
이미징 CRO 세계 시장 규모는 2025년에 56억 1,000만 달러, 2032년에는 96억 8,000만 달러에 이르고, 2025-2032년 CAGR 8.1%로 성장할 전망입니다.
| 보고서 범위 |
보고서 상세 |
| 기준 연도 |
2024 |
2025년 시장 규모 |
56억 1,000만 달러 |
| 실적 데이터 |
2020-2024년 |
예측 기간 |
2025-2032년 |
| 예측 기간(2025-2032년) CAGR |
8.10% |
2032년 가치 예측 |
96억 8,000만 달러 |
세계 이미징 CRO 시장은 헬스케어 산업에서 중요한 분야로 부상하고 있으며, 의료 이미징 기술 개발 및 개척에 있어 매우 중요한 역할을 하고 있습니다. 이미징 CRO(Contract Research Organizations)는 임상시험 및 조사 연구를 지원하기 위해 영상 진단 프로토콜 설계, 이미지 수집, 분석 및 판독을 포함한 다양한 서비스를 제공하는 것을 전문으로 합니다. 이들 조직은 최첨단 기술과 전문 지식을 활용하여 제약회사와 생명공학 기업이 의약품 개발 과정에서 정보에 입각한 의사결정을 내릴 수 있도록 고품질의 영상 데이터를 제공합니다. 만성질환 증가, 개인 맞춤형 의료에 대한 수요 증가, 효율적이고 비용 효율적인 의약품 개발의 필요성이 세계 이미징 CRO 시장의 성장에 박차를 가하고 있습니다. 헬스케어 환경이 계속 진화함에 따라 혁신적인 치료법 개발을 가속화하고 환자의 예후를 개선하는 데 있어 이미징 CRO의 역할이 점점 더 중요해지고 있습니다.
시장 역학
세계 이미징 CRO 시장의 성장은 만성 질환의 확산, 첨단 이미징 기술에 대한 수요 증가, 효율적이고 비용 효율적인 의약품 개발 프로세스에 대한 요구 증가 등 몇 가지 주요 요인에 의해 주도되고 있습니다. 인구 고령화와 라이프스타일의 변화로 인해 암, 심혈관 질환, 신경 질환과 같은 만성 질환의 발병률이 증가하고 있으며, 진단 및 모니터링에 첨단 영상 기술이 요구되고 있습니다. 또한, 개인 맞춤형 의료의 출현으로 표적 치료의 개발이 필요하게 되었고, 환자 선택과 치료 반응성 평가를 위해 영상 바이오마커에 크게 의존하고 있습니다. 그러나 영상 장비의 높은 비용, 복잡한 규제 요건, 이 분야의 숙련된 전문가 부족 등의 요인으로 인해 시장 성장이 제한될 수 있습니다.
또한, 이미징 프로토콜과 데이터 관리의 표준화 부족은 이미징 CRO가 서로 다른 시설과 연구 간에 이미징 데이터의 신뢰성과 재현성을 보장하는 데 어려움을 겪고 있습니다. 이러한 도전에도 불구하고, 인공지능, 머신러닝, 클라우드 컴퓨팅 등 영상진단의 전망을 바꾸고 있는 기술의 발전은 시장에 큰 성장 기회를 가져다주고 있습니다. 이러한 기술은 보다 빠르고 정확한 영상 분석을 가능하게 하고, 데이터 관리를 간소화하며, 이해관계자간의 원격 협업을 촉진합니다. 또한 PET/CT 및 PET/MRI와 같은 하이브리드 이미징 양식의 채택이 증가함에 따라 멀티모달 이미징 연구를 지원하는 이미징 CRO의 범위가 확대될 것으로 예측됩니다.
본 조사의 주요 특징
- 세계의 이미징 CRO 시장에 대해 조사 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모(10억 달러)와 연평균 성장률(CAGR)을 조사하여 전해드립니다.
- 또한, 다양한 부문에 걸친 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 주요 고찰을 제공합니다.
- 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 이미징 CRO 시장의 주요 기업을 프로파일링합니다.
- 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- 이미징 CRO 세계 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 이미징 CRO 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 성장 촉진요인
- 성장 억제요인
- 기회
- 영향 분석
- 주요 발전
- 규제 시나리오
- 제품 발매/승인
- PEST 분석
- PORTER 분석
- 인수합병(M&A) 시나리오
- 업계 동향
제4장 세계의 이미징 CRO 시장, 서비스 유형별, 2020년-2032년
- 임상시험 이미징
- 전임상 이미징
- 의료 영상 데이터 관리
- 영상 처리 및 분석 서비스
- 규제 컨설팅
- 기타(품질관리 등)
제5장 세계의 이미징 CRO 시장, 이미징 모달리티별, 2020년-2032년
- 자기 공명 영상(MRI)
- 컴퓨터 단층촬영(CT)
- 양전자 방출 단층촬영(PET)
- 초음파
- X선
- 광학 이미징
제6장 세계의 이미징 CRO 시장, 치료 영역별, 2020년-2032년
- 종양학
- 신경학
- 심장병학
- 근골격계 장애
- 소화기내과
- 내분비학
- 기타
제7장 세계의 이미징 CRO 시장, 임상시험 단계별, 2020년-2032년
제8장 세계의 이미징 CRO 시장, 최종사용자별, 2020년-2032년
- 제약회사
- 바이오테크놀러지 기업
- 의료기기 제조업체
- 진단센터
- 수탁연구기관
- 학술연구기관
제9장 세계의 이미징 CRO 시장, 지역별, 2020년-2032년
- 북미
- 라틴아메리카
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- 아프리카
제10장 경쟁 구도
- Siemens Healthineers
- GE Healthcare
- Philips Healthcare
- Canon Medical Systems
- Fujifilm Holdings Corporation
- Agfa-Gevaert Group
- Hitachi Medical Corporation
- Carestream Health
- Hologic, Inc.
- Toshiba Medical Systems
- Mindray Medical International Limited
- Varian Medical Systems
- Esaote S.p.A.
- Bracco Imaging S.p.A.
- Leica Biosystems
제11장 애널리스트 추천 사항
- 기회
- 애널리스트의 견해
- Coherent Opportunity Map
제12장 참고 문헌과 조사 방법
LSH
영문 목차
Global Imaging CRO Market is estimated to be valued at USD 5.61 Bn in 2025 and is expected to reach USD 9.68 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.1% from 2025 to 2032.
| Report Coverage |
Report Details |
| Base Year: |
2024 |
Market Size in 2025: |
USD 5.61 Bn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: |
8.10% |
2032 Value Projection: |
USD 9.68 Bn |
The global imaging CRO market has emerged as a crucial sector within the healthcare industry, playing a pivotal role in the development and advancement of medical imaging technologies. Imaging Contract Research Organizations (CROs) specialize in providing a wide range of services, including imaging protocol design, image acquisition, analysis, and interpretation, to support clinical trials and research studies. These organizations leverage cutting-edge technologies and expertise to deliver high-quality imaging data, enabling pharmaceutical and biotechnology companies to make informed decisions during the drug development process. The increasing prevalence of chronic diseases, coupled with the growing demand for personalized medicine and the need for efficient and cost-effective drug development, has fueled the growth of the global imaging CRO market. As the healthcare landscape continues to evolve, the role of imaging CROs is becoming increasingly important in accelerating the development of innovative therapies and improving patient outcomes.
Market Dynamics
The global imaging CRO market growth is driven by several key factors, including the increasing prevalence of chronic diseases, rising demand for advanced imaging technologies, and the growing need for efficient and cost-effective drug development processes. The aging population and changing lifestyles have led to a higher incidence of chronic conditions such as cancer, cardiovascular diseases, and neurological disorders, which require advanced imaging techniques for diagnosis and monitoring. Additionally, the advent of personalized medicine has necessitated the development of targeted therapies, which rely heavily on imaging biomarkers for patient selection and treatment response assessment. However, the market growth may be restrained by factors such as the high cost of imaging equipment, complex regulatory requirements, and the shortage of skilled professionals in the field.
Furthermore, the lack of standardization in imaging protocols and data management poses challenges for imaging CROs in ensuring the reliability and reproducibility of imaging data across different sites and studies. Despite these challenges, the market presents significant opportunities for growth, driven by technological advancements such as artificial intelligence, machine learning, and cloud computing, which are transforming the imaging landscape. These technologies enable faster and more accurate image analysis, streamline data management, and facilitate remote collaboration among stakeholders. Moreover, the increasing adoption of hybrid imaging modalities, such as PET/CT and PET/MRI, is expected to expand the scope of Imaging CROs in supporting multimodal imaging studies.
Key Features of the Study
- This report provides in-depth analysis of the global imaging CRO market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global Imaging CRO market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems, Fujifilm Holdings Corporation, Agfa-Gevaert Group, Hitachi Medical Corporation, Carestream Health, Hologic, Inc., Toshiba Medical Systems, Mindray Medical International Limited, Varian Medical Systems, Esaote S.p.A., Bracco Imaging S.p.A., and Leica Biosystems
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global imaging CRO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global imaging CRO market
Market Segmentation
- Service Type Insights (Revenue, USD Bn, 2020 - 2032)
- Clinical Trial Imaging
- Preclinical Imaging
- Medical Imaging Data Management
- Image Processing & Analysis Services
- Regulatory Consultancy
- Others (Quality Control, etc.)
- Imaging Modality Insights (Revenue, USD Bn, 2020 - 2032)
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
- Positron Emission Tomography (PET)
- Ultrasound
- X-ray
- Optical Imaging
- Therapeutic Area Insights (Revenue, USD Bn, 2020 - 2032)
- Oncology
- Neurology
- Cardiology
- Musculoskeletal Disorders
- Gastroenterology
- Endocrinology
- Others
- Clinical Trial Phase Insights (Revenue, USD Bn, 2020 - 2032)
- Phase I
- Phase II
- Phase III
- Phase IV
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Pharmaceutical Companies
- Biotechnology Companies
- Medical Device Manufacturers
- Diagnostic Centers
- Contract Research Organizations
- Academic and Research Institutes
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Siemens Healthineers
- GE Healthcare
- Philips Healthcare
- Canon Medical Systems
- Fujifilm Holdings Corporation
- Agfa-Gevaert Group
- Hitachi Medical Corporation
- Carestream Health
- Hologic, Inc.
- Toshiba Medical Systems
- Mindray Medical International Limited
- Varian Medical Systems
- Esaote S.p.A.
- Bracco Imaging S.p.A.
- Leica Biosystems
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Imaging CRO Market, By Service Type
- Global Imaging CRO Market, By Imaging Modality
- Global Imaging CRO Market, By Therapeutic Area
- Global Imaging CRO Market, By Clinical Trial Phase
- Global Imaging CRO Market, By End User
- Global Imaging CRO Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Imaging CRO Market, By Service Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Clinical Trial Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Preclinical Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Medical Imaging Data Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Image Processing & Analysis Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Regulatory Consultancy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Quality Control, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Imaging CRO Market, By Imaging Modality, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Magnetic Resonance Imaging (MRI)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Computed Tomography (CT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Positron Emission Tomography (PET)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ultrasound
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- X-ray
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Optical Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Imaging CRO Market, By Therapeutic Area, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Musculoskeletal Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Gastroenterology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Endocrinology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Imaging CRO Market, By Clinical Trial Phase, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Phase I
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Phase II
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Phase III
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Phase IV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Imaging CRO Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Medical Device Manufacturers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Imaging CRO Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Imaging Modality, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Clinical Trial Phase, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Latin America
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Imaging Modality, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Clinical Trial Phase, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Imaging Modality, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Clinical Trial Phase, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Imaging Modality, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Clinical Trial Phase, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Imaging Modality, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Clinical Trial Phase, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Imaging Modality, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Clinical Trial Phase, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GE Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Philips Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Canon Medical Systems
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fujifilm Holdings Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agfa-Gevaert Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hitachi Medical Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Carestream Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hologic, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Toshiba Medical Systems
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mindray Medical International Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Varian Medical Systems
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Esaote S.p.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bracco Imaging S.p.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Leica Biosystems
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
관련자료
